Filing Details
- Accession Number:
- 0000899243-20-034497
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-18 17:14:39
- Reporting Period:
- 2020-12-16
- Accepted Time:
- 2020-12-18 17:14:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1463361 | Unity Biotechnology Inc. | UBX | Pharmaceutical Preparations (2834) | 264726035 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1559531 | E Nathaniel David | C/O Unity Biotechnology, Inc. 285 East Grand Avenue South San Francisco CA 94080 | President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.0001 Par Value | Disposition | 2020-12-16 | 1,700,000 | $5.24 | 624,703 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Includes Restricted Stock Units which vest over time measured from the grant date.